Portugal vs Slovenia: Access to anti-retroviral drugs, female
Portugal
82.0%
in 2017
Slovenia
83.0%
in 2024
Portugal rank
56th
Slovenia rank
53rd
Access to anti-retroviral drugs, female over time
- Portugal
- Slovenia
How they compare
Slovenia currently reports 83.0% against 82.0% in Portugal, a difference of 1.0%.
The two have swapped places 1 time across 18 shared years of data; in 2000 it was Slovenia ahead.
Portugal ranks 56th and Slovenia ranks 53rd of 141 countries.
Portugal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Portugal | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.8% | 28.3% | 8.5% | Portugal |
| 2010s | 68.2% | 53.8% | 14.5% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Portugal or Slovenia?
- Slovenia, at 83.0% against 82.0% in Portugal as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Portugal and Slovenia?
- 1.0%, with Slovenia ahead.
- How many years of comparable data are there for Portugal and Slovenia?
- 18 years are reported by both, from 2000 to 2017.
- How do Portugal and Slovenia rank globally for access to anti-retroviral drugs, female?
- Portugal ranks 56th and Slovenia ranks 53rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.